바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev
e-Submission

Vol.80 No.2
Citation Share

Cutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2017, v.80 no.2, pp.210-211


& (2017). Cutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment. Tuberculosis & Respiratory Diseases, 80(2), 210-211.
  • Downloaded
  • Viewed
PDF Download

Abstract

keywords

Reference

1.

1. Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 2005;27:504-28.

2.

2. Avcu G, Sensoy G, Celiksoy MH, Sogut A, Kefeli M, Karli A, et al. Cutaneous leukocytoclastic vasculitis associated with antituberculosis drugs. Pediatr Int 2015;57:155-7.

3.

3. Kim JH, Moon JI, Kim JE, Choi GS, Park HS, Ye YM, et al. Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide. Allergy Asthma Immunol Res 2010;2:55-8.

4.

4. Calabrese LH, Michel BA, Bloch DA, Arend WP, Edworthy SM, Fauci AS, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1990;33:1108-13.

5.

5. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936-41.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy